Nova Patents
AT293113T

New polymorphic forms of olanzapine

Abstract

Disclosed is a method for producing a olanzapine polymorph comprising: dissolving a starting olanzapine polymorph in an aqueous acid solution, wherein the aqueous acid solution comprises an acid selected from the group of organic or inorganic acids, and cases of another olanzapine polymorph by neutralization; wherein the neutralization by the addition of an aqueous or alcoholic solution of a base is brought about, and the use of olanzapine polymorph for the preparation of a pharmaceutical composition for treating a condition selected from the group of psychotic states, mild anxiety and gastrointestinal complaints.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

29 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
977BO1999IndiaA
54074900United States of AmericaA
0004982United KingdomW

Members29

Family members, oldest first
DocumentOfficeKind
CA2395774A1CanadaA1
WO0147933A1World Intellectual Property Organization (WIPO)A1
AU2017601AAustraliaA
US6348458B1United States of AmericaB1
IN187439BIndiaB
EP1246827A1European Patent Office (EPO)A1
US2002165225A1United States of AmericaA1
DE20023184U1GermanyU1
DK200300161U1DenmarkU1
ZA200205228BSouth AfricaB
DK200300221U1DenmarkU1
DK200300222U1DenmarkU1
DK200300161U3DenmarkU3
DK200300221U3DenmarkU3
DK200300222U3DenmarkU3
NZ519926ANew ZealandA
AT6739U1AustriaU1
NZ528520ANew ZealandA
AU779452B2AustraliaB2
EP1246827B1European Patent Office (EPO)B1
AT293113TThis recordAustriaT
ATE293113T1AustriaT1
DE60019461D1GermanyD1
DK1246827T3DenmarkT3
PT1246827EPortugalE
DE60019461T2GermanyT2
ES2240215T3SpainT3
US7022698B2United States of AmericaB2
CA2395774CCanadaC